Carisma Therapeutics Inc (NASDAQ: CARM): How Much Is It Worth And What Should Investors Do?
During the last session, Carisma Therapeutics Inc (NASDAQ:CARM)’s traded shares were 0.52 million, with the beta value of the company hitting 1.53. At the end